Osborne Clarke advises on GBP50m Life Science Venture Capital Funding
Osborne Clarke, has advised a group of investors consisting of Imperial Innovations, Invesco Perpetual and Woodford Investment Management on the GBP50m Venture Capital funding of Cell Medica Limited. Partner Rob Wood, who led the Osborne Clarke team assisted by Senior Associate Caroline Drummond, says: “This is a significant deal in



